Chinese drug developer SinocellTech nearly trebled in value on its first day of trading on China's Science and Technology Innovation Board (Star Market) following a RMB1.28 billion ($181 million) IPO.
The company sold 50 million shares at RMB25.6 apiece. It then opened RMB85 on June 22, becoming the largest biotech player listed on the Star Market with a market capitalization of RMB37 billion. SinocellTech...
SoftBank Vision Fund 2 is the largest participant in a KRW223.6 billion ($187 million) investment in Naver Z, the metaverse platform unit of Korean internet giant Naver Corporation.
Horizons Ventures, the private investment arm of Hong Kong billionaire Li Ka-Shing, has led a A$129 million ($92.3 million) Series B round for Australia’s Harrison.ai, a clinical artificial intelligence (AI) developer.
Airbus Ventures has led a $25 million Series B round for Australia’s Q-Ctrl, a quantum computing developer increasingly geared toward space tech and orbital infrastructure.
STIC Investments has led a KRW1 trillion ($840 million) investment in Iljin Materials, a Korean producer of electric foils used in lithium batteries and consumer electronics, to support the international expansion of its manufacturing footprint.